Pacira Pharmaceuticals Aktie

20,22 EUR +0,39 EUR +1,95 %

22:14:21

BMN

23,48 USD +0,36 USD +1,54 %

20:59:53

BTT

Pacira Pharmaceuticals jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.809,94 Mio. EUR

KGV165,69Div. Rendite0,00%

WKNA1H68T

ISINUS6951271005

SymbolPCRX

Pacira Pharmaceuticals Aktien News

Sortieren:Datum Meistgelesen

30.12.25PR NewswireDOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc.

11.11.25PR NewswireDOMA Perpetual Sends Letter Calling for the Board of Directors of Pacira BioSciences, Inc. to Immediately Explore a Sale of the Business

06.11.25PR NewswireCanadian Investment Regulatory Organization Trade Resumption - PCRX

WerbungPacira Pharmaceuticals-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

06.11.25PR NewswireCanadian Investment Regulatory Organization Trade Resumption - PCRX

05.11.25PR NewswireCanadian Investment Regulatory Organization Trading Halt - PCRX

16.07.25PR NewswireInvestors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with Lawsuit

13.05.25PR NewswireLawsuit for Investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) announced by the Shareholders Foundation

21.04.25PR NewswireDOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders

14.03.25PR NewswireDOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences

11.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - PCRX

03.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - PCRX

27.02.25PR NewswirePCRX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In PCRX To Contact Him Directly To Discuss Their Options

19.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - PCRX

12.02.25PR NewswirePCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit

11.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - PCRX

07.02.25PR NewswireShareholders that lost money on Pacira BioSciences, Inc.(PCRX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

04.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - PCRX

03.02.25PR NewswireThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Pacira BioSciences, Inc.(PCRX) Shareholders

30.01.25PR NewswireThe Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc. (PCRX) of a Class Action Lawsuit and an Upcoming Deadline

29.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - PCRX

28.01.25PR NewswireLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira BioSciences, Inc. Lawsuit - PCRX

24.01.25PR NewswirePCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

23.01.25PR NewswireInvestors who lost money on Pacira BioSciences, Inc.(PCRX) should contact The Gross Law Firm about pending Class Action - PCRX

21.01.25PR NewswirePacira BioSciences, Inc. Class Action: Levi & Korsinsky Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX

17.01.25PR NewswireLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira Lawsuit - PCRX

16.01.25PR NewswirePCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

15.01.25PR NewswirePCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit

11.12.24PR NewswireDOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc.

25.09.24PR NewswireCanadian Investment Regulatory Organization Trade Resumption - PCRX

25.09.24PR NewswireCanadian Investment Regulatory Organization Trading Halt - PCRX

25.09.24PR NewswireDOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to Shareholders

01.02.24PR NewswireG.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams

Pacira Pharmaceuticals News

Pacira Pharmaceuticals News: auf dieser Seite finden Sie alle Pacira Pharmaceuticals News und Nachrichten zur Pacira Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Pacira Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Pacira Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.